Brain Biotech Ag · XETR:BNN
Brain Biotech — Investor Day (February 2023)
10 slides from Brain Biotech's investor day presentation, Feb 27, 2023
Slide 1: BRAIN Biotech AG Capital Markets Day 2023
BRAIN Biotech AG Creating a #BiobasedFuture Capital Markets Day 2023 Zwingenberg, February 27, 2023 Since 2021 we have been committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, the environment and anti-corruption. Creating a #
Slide 2: BRAINnext: BRAIN Group Evolution
Capital Markets Day 2023 Creating a #BiobasedFuture BRAINnext: BRAIN Group Evolution Adriaan Moelker, CEO Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg Germany www.brain-biotech.com +49 (0) 6251-9331-0 4
Slide 3: Evolution of the BRAIN Biotech Group
Evolution of the BRAIN Biotech Group from a science campus to an integrated solutions provider Transformational M&A CRISPR USP / Akribion Enterprise Value Drivers TMS+ Akribion Geographic expansion Genomics Bolt-on One BioProducts Breatec Bolt-on Biocatalysts WeissBioTech Bolt-on Building an integra
Slide 4: Three BRAIN Group Strategic Imperatives for 2023 and beyond
Three BRAIN Group Strategic Imperatives for 2023 and beyond 1. Establish Biocatalysts / BioProducts as a Top 10 Enzyme Business niche/food focus synergistic food ingredient portfolio EU/US as core geographic markets focus on submerged fermentation strong organic growth accretive M&A 2. E
Slide 5: BRAIN Biotech Business on a Page
BRAIN Biotech Business on a Page integrated solutions provider Revenue Streams by Business Segment Enzymes and Producer strains & BioActive compounds Proteins Microorganisms Small Molecules End Markets Science Products Science Products Science Products Dairy, cheese ✓ ✓ ✓ ✓ Beverages ✓ ✓ ✓ ✓ ✓ Susta
Slide 6: Strong Strategic Fit: BioProducts, BRAIN Zwingenberg and Genome Editing
Strong Strategic Fit: BioProducts, BRAIN Zwingenberg and Genome Editing USPs and integrated solutions competency for our customers Discovery Protein and Enzyme Expression/Secretion: Large Scale Formulation Marketing and Engineering Bioprocesses & scale-up Fermentation And Blending Sales BRAIN Zwinge
Slide 7: BioProducts: Food and Beverage Enzymes Addressable Segments & Regions
BioProducts: Food and Beverage Enzymes Addressable Segments & Regions multi-niche enzyme champion in attractive markets Focus: Baking – Dairy – Beverages – Food Processing Baking Dairy Beverages Food processing Baking Dairy Fruits & Wine Brewing Starch & Protein Egg Processing Carbohydrate Fats & O
Slide 8: Key accomplishments – last 36 months
Key accomplishments – last 36 months major milestone successfully achieved Culture development: towards accountability and profitability – BRAINway company program Growth initiatives: two capital increases successfully executed for funding Portfolio management: one disposal, two acquisitions – no
Slide 9: … so what??
… so what?? the accomplishments go back to three core themes Accountability Drive for Profitability Further strengthening our USP: world-class expression/secretion from our proprietary host organisms Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg Germany www.brain-biotech.com +49 (0
Slide 10: Looking 12 months ahead: our must do goals
Looking 36 months ahead our 8must do9 goals Drive to profitability continued Merge the BioProducts businesses and drive for profitable growth. Extract synergies Build our technology platforms; Genome Editing, Process development, discovery, expression/secretion, scale up Strengthen the organizat